Reviews

Current Reviews

• Rapid review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS)
• Review of PBS Prescriber Bag Schedule

Current Post-market Reviews

• There are no current Post-market Reviews.

What are Post-Market Reviews of PBS listed Medicines?

• Post-market Reviews of Pharmaceutical Benefits Scheme subsidised medicines

• Post market Reviews of Pharmaceutical Benefits Scheme subsidised medicines – plain English version (PDF 262KB) - (Word 86KB)

Completed Post-market Reviews

• Opiate Dependence Treatment Program
• Medicines for smoking cessation
• The use of biologics in the treatment of severe chronic plaque psoriasis
• Pulmonary Arterial Hypertension (PAH) Medicines
• Chronic Obstructive Pulmonary Disease (COPD) Medicines
• Ezetimibe
• Alzheimers Disease medicines
• Anticoagulation Therapies in Atrial Fibrillation
• Asthma in Children
• Diabetes

Completed Other Reviews

• Utilisation analysis of PBS-listed disease modifying therapies for relapsing-remitting multiple sclerosis
• Monitoring system for final trial overall survival results for cancer medicines
• Lamotrigine for bipolar disorder
• PBS restriction changes for antihypertensive dual therapy fixed dose combinations
• PBAC advice on equitable access to GLP-1 obesity treatments
• Review of PBS items for prescribing by nurse practitioners and endorsed midwives
• Review of clinical guidelines and cost estimates for the use of anti-epileptic drugs (AEDs) for the treatment of epilepsy
• Utilisation analysis of PBS-listed heart failure medicines
• PBS restrictions for ezetimibe and its fixed dose combinations
• PBS restriction changes to type 2 diabetes mellitus (T2DM) medicines
• Stocktake of PBS medicines available for endometriosis and related conditions, and comparison of current Australian pharmacological treatment guidelines (2022)
• Pharmaceutical Reform Agreement (PRA) Review Report
• Review of cancer related surrogate outcomes used for Pharmaceutical Benefits Advisory Committee (PBAC) decision making
• Efficient Funding of Chemotherapy Review
• Overall survival in people receiving PBS-listed cancer medicines in Australian clinical practice
• PBS Pharmaceuticals in Hospitals Review
• Review of Pharmacy Remuneration and Regulation
• Life Saving Drugs Program
• Pharmaceutical Benefits Advisory Committee Guidelines (PBAC) Review
• Independent Review (PBS)
• Independent Review of the Impact of PBS Cost Recovery
• Streamlined Authorities (PDF 153KB)
• Review of Post PBAC Processes Report (2004)